UniProt ID | KCC1D_HUMAN | |
---|---|---|
UniProt AC | Q8IU85 | |
Protein Name | Calcium/calmodulin-dependent protein kinase type 1D | |
Gene Name | CAMK1D | |
Organism | Homo sapiens (Human). | |
Sequence Length | 385 | |
Subcellular Localization | Cytoplasm . Nucleus . Predominantly cytoplasmic. Nuclear localization increases upon activation by KCl treatment in hippocampal neurons. | |
Protein Description | Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and promotes basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Activates the transcription factor CREB1 in hippocampal neuron nuclei. May play a role in apoptosis of erythroleukemia cells. In vitro, phosphorylates transcription factor CREM isoform Beta.. | |
Protein Sequence | MARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQIRKNFAKSKWRQAFNATAVVRHMRKLHLGSSLDSSNASVSSSLSLASQKDCLAPSTLCSFISSSSGVSGVGAERRPRPTTVTAVHSGSK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MARENGESSSSWKKQ CCCCCCCCCHHHHHH | 36.60 | - | |
43 | Ubiquitination | EVVLAEEKATGKLFA EEEEEEHHHCCCEEE | 42.63 | - | |
52 | Ubiquitination | TGKLFAVKCIPKKAL CCCEEEEEEECHHHH | 24.02 | - | |
62 | Ubiquitination | PKKALKGKESSIENE CHHHHCCCCCCHHHH | 53.49 | - | |
64 | Phosphorylation | KALKGKESSIENEIA HHHCCCCCCHHHHHH | 39.85 | 28122231 | |
65 | Phosphorylation | ALKGKESSIENEIAV HHCCCCCCHHHHHHH | 34.71 | 24076635 | |
113 | Sumoylation | LFDRIVEKGFYTEKD HHHHHHHCCCCCHHH | 43.35 | 25218447 | |
113 | Sumoylation | LFDRIVEKGFYTEKD HHHHHHHCCCCCHHH | 43.35 | - | |
122 | Phosphorylation | FYTEKDASTLIRQVL CCCHHHHHHHHHHHH | 33.60 | 18669648 | |
123 | Phosphorylation | YTEKDASTLIRQVLD CCHHHHHHHHHHHHH | 28.11 | 29083192 | |
152 | Phosphorylation | LKPENLLYYSQDEES CCHHHCEEECCCCCC | 12.30 | 27642862 | |
153 | Phosphorylation | KPENLLYYSQDEESK CHHHCEEECCCCCCC | 10.38 | 23312004 | |
154 | Phosphorylation | PENLLYYSQDEESKI HHHCEEECCCCCCCE | 20.00 | 23312004 | |
159 | Phosphorylation | YYSQDEESKIMISDF EECCCCCCCEEEEHH | 25.99 | 23312004 | |
174 | Acetylation | GLSKMEGKGDVMSTA CCCCCCCCCCHHCCC | 38.33 | 7678613 | |
179 | Phosphorylation | EGKGDVMSTACGTPG CCCCCHHCCCCCCCC | 16.83 | 23401153 | |
180 | Phosphorylation | GKGDVMSTACGTPGY CCCCHHCCCCCCCCC | 14.10 | 23401153 | |
184 | Phosphorylation | VMSTACGTPGYVAPE HHCCCCCCCCCCCHH | 17.27 | 25627689 | |
187 | Phosphorylation | TACGTPGYVAPEVLA CCCCCCCCCCHHHHC | 8.47 | 23312004 | |
196 | Ubiquitination | APEVLAQKPYSKAVD CHHHHCCCCCCCHHH | 40.07 | - | |
196 | Acetylation | APEVLAQKPYSKAVD CHHHHCCCCCCCHHH | 40.07 | 7678625 | |
238 | Phosphorylation | EQILKAEYEFDSPYW HHHHHHHCCCCCCCC | 27.10 | 21951684 | |
262 | Acetylation | FIRNLMEKDPNKRYT HHHHHHHHCCCCCCC | 65.60 | 7462123 | |
268 | Phosphorylation | EKDPNKRYTCEQAAR HHCCCCCCCHHHHHH | 19.83 | 28176443 | |
269 | Phosphorylation | KDPNKRYTCEQAARH HCCCCCCCHHHHHHC | 17.38 | 28176443 | |
287 | Ubiquitination | AGDTALNKNIHESVS CCCHHHCCCHHHHHH | 59.12 | - | |
292 | Phosphorylation | LNKNIHESVSAQIRK HCCCHHHHHHHHHHH | 13.75 | 22210691 | |
294 | Phosphorylation | KNIHESVSAQIRKNF CCHHHHHHHHHHHHH | 24.60 | 22210691 | |
313 | Phosphorylation | WRQAFNATAVVRHMR HHHHHHHHHHHHHHH | 22.53 | 28857561 | |
326 | Phosphorylation | MRKLHLGSSLDSSNA HHHHCCCCCCCCCCC | 33.80 | 25159151 | |
327 | Phosphorylation | RKLHLGSSLDSSNAS HHHCCCCCCCCCCCC | 34.10 | 25159151 | |
331 | Phosphorylation | LGSSLDSSNASVSSS CCCCCCCCCCCHHHH | 35.76 | 25307156 | |
338 | Phosphorylation | SNASVSSSLSLASQK CCCCHHHHHHHHHCC | 17.93 | 22817900 | |
349 (in isoform 2) | Phosphorylation | - | 11.43 | 26552605 | |
352 | O-linked_Glycosylation | KDCLAPSTLCSFISS CCCCCHHHHHHHHHH | 30.63 | 23301498 | |
355 (in isoform 2) | Phosphorylation | - | 28.82 | 21712546 | |
355 | Phosphorylation | LAPSTLCSFISSSSG CCHHHHHHHHHHCCC | 28.82 | 28348404 | |
357 (in isoform 2) | Phosphorylation | - | 1.93 | 28674419 | |
358 | Phosphorylation | STLCSFISSSSGVSG HHHHHHHHHCCCCCC | 23.35 | 28348404 | |
375 | Phosphorylation | AERRPRPTTVTAVHS CCCCCCCCEEEEEEC | 34.87 | 23312004 | |
376 | Phosphorylation | ERRPRPTTVTAVHSG CCCCCCCEEEEEECC | 20.67 | 27732954 | |
378 | Phosphorylation | RPRPTTVTAVHSGSK CCCCCEEEEEECCCC | 22.37 | 27732954 | |
382 | Phosphorylation | TTVTAVHSGSK---- CEEEEEECCCC---- | 37.86 | 27732954 | |
384 | Phosphorylation | VTAVHSGSK------ EEEEECCCC------ | 37.90 | 29214152 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KCC1D_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCC1D_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122 AND THR-180, ANDMASS SPECTROMETRY. | |
"Identification and characterization of novel components of aCa2+/calmodulin-dependent protein kinase cascade in HeLa cells."; Ishikawa Y., Tokumitsu H., Inuzuka H., Murata-Hori M., Hosoya H.,Kobayashi R.; FEBS Lett. 550:57-63(2003). Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 1), CATALYTIC ACTIVITY, ENZYMEREGULATION, PHOSPHORYLATION AT THR-180, PHOSPHORYLATION BY CAMKK1 ANDCAMKK2, MUTAGENESIS OF THR-180, AND TISSUE SPECIFICITY. |